Search
teduglutide (Gattex)
Indications:
- treatment of short bowel syndrome
Contraindications:
- not for treatment of chronic watery diarrhea after ileal resection in patients with Crohn's disease [4] Dosge:
Injection: 5 mg
Mechanism of action:
- glucagon-like peptide-2
General
glucagon-like peptide 2 (GLP2)
gastrointestinal agent
Database Correlations
PUBCHEM cid=16139605
References
- RxNorm
- PubChem: 16139605
- Jeppesen PB
Teduglutide, a novel glucagon-like peptide 2 analog, in the
treatment of patients with short bowel syndrome
Therap Adv Gastroenterol. 2012 May; 5(3): 159-171.
PMID: 22570676
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342570/
- NEJM Knowledge+